Aimei Health Technology Co., Ltd (AFJK) Analysis

This report is auto-generated by an AI stock research platform for informational purposes only. The content is for general information and research reference, and does not constitute financial advice. Data may lag or be incomplete. Always conduct your own research and consult qualified professionals before making any financial decisions. # [Qiltrack AI] Aimei Health Technology Co Ltd (AFJK) 3-Minute Overview ### 🎯 Layer 1: 30-Second Key Takeaways > **💡 One-Sentence Summary** > > Simply put, AFJK looks like a very small, newly listed stock with a huge recent price spike, very limited public operating detail in this dataset, and a risk/reward profile that feels much more speculative than proven. > **📍 Basic Profile** > > Market Cap **$0.17 billion** · [Industry unavailable] · NASDAQ NMS - GLOBAL MARKET · Price **$67.86** > **⚡ 3 Things You Should Know** > > 1. 📈 Wild price action: The stock jumped more than 140% in a single session and is trading far above its 52-week low, which usually means sentiment is driving the story more than fundamentals right now. > > 2. ⚠️ Liquidity looks extremely tight: A current ratio of just 0.009 and quick ratio of 0.0345 are both far below normal comfort levels, so if these figures are accurate, short-term balance sheet flexibility is a real concern. > > 3. 💸 Valuation is already assuming a lot: At roughly 122x trailing earnings while ROE is only 2.85%, the market appears to be pricing in a much better future than the company has demonstrated so far. > **🎯 Quick Health Check** > > | Dimension | Rating | Details | > |-----------|--------|---------| > | Profitability | Weak👎 | ROE 2.85%, suggesting low current earnings power | > | Growth Rate | [Data unavailable] | No revenue/profit growth series provided | > | Financial Health | Tight🧡 | Current ratio 0.009, well below healthy levels | > | Valuation | Expensive | PE 121.93x | --- ### 📋 Layer 2: 2-Minute Deep Dive #### 📊 How Does This Company Make Money? **Business Model in One Sentence:** [Data unavailable] — the company name suggests health technology, but this dataset does not provide product, customer, or revenue-model details. **Revenue Breakdown:** | Business | Share | Trend | Comment | |----------|-------|-------|---------| | [Data unavailable] | [Data unavailable] | [Data unavailable] | No segment disclosure in the provided data | | [Data unavailable] | [Data unavailable] | [Data unavailable] | No segment disclosure in the provided data | **Profitability Metrics:** | Metric | Value | Ranking | Interpretation | |--------|-------|---------|----------------| | Gross Margin | [Data unavailable] | [Data unavailable] | No margin detail provided | | Net Margin | [Data unavailable] | [Data unavailable] | No net margin detail provided | | ROE | 2.85% | Average-to-below average | Basically, shareholder capital is not generating strong returns yet | --- #### 📈 How's the Growth? **Growth Assessment:** [Data unavailable] | Metric | Latest | vs Last Year | Trend | |--------|--------|--------------|-------| | Revenue Growth | [Data unavailable] | [Data unavailable] | [Data unavailable] | | Profit Growth | [Data unavailable] | [Data unavailable] | [Data unavailable] | **Growth Quality:** > [Data unavailable] — what’s worth noting is that without revenue history, earnings trend, or segment disclosure, it’s hard to tell whether the market is reacting to actual business progress or just trading momentum. --- #### 💰 Financial Health Check **One Sentence:** This looks a bit like someone who technically has very little debt, but almost no cash in their checking account to handle near-term bills. | Metric | Value | Safe Zone | Assessment | |--------|-------|-----------|------------| | Debt Ratio | [Data unavailable] | <60% safe | [Data unavailable] | | Current Ratio | 0.009 | >1.5 healthy | 🚨Dangerous | | Cash Flow | [Data unavailable] | >0 | [Data unavailable] | Additional context: - **Debt-to-equity is only 0.0031**, which is very low and normally a plus. - But **low debt does not automatically mean healthy finances** if working capital is extremely weak. - In other words, solvency may not be the immediate issue here — liquidity may be. --- #### 🏷️ Is It Expensive Now? **Price Position (based on 52-week range):** - 52-Week Low: $6.75 - 52-Week High: $130.37 - Current: $67.86, **In the middle** | Position Range | Cheap Zone | Fair Zone | Pricey Zone | |----------------|------------|-----------|-------------| | Criteria | 0-33% | 33-66% | 66-100% | | **Current** | | ●(49.4% position) | | **Valuation Comparison:** | Comparison | Current | Reference | Assessment | |------------|---------|-----------|------------| | vs Own History | PE 121.93x | 5-year avg [Data unavailable] | [Data unavailable] | | vs Peers | PE 121.93x | Industry avg [Data unavailable] | [Data unavailable] | **What the Current Valuation is Betting On:** > Basically, this kind of valuation only makes sense if the market believes earnings can scale sharply from here, or that there is some catalyst not visible in the current fundamentals. If that doesn’t happen, the stock has little room for disappointment. --- #### 📰 Any Recent News? | Date | Event | Impact | |------|-------|--------| | [Data unavailable] | No recent news provided in dataset | Neutral — lack of news makes the recent price surge harder to explain fundamentally | | [Data unavailable] | No analyst or company event data provided | Neutral — market may be trading on factors outside this dataset | --- ### 📊 Layer 3: Want More? 3-Minute Complete Analysis #### I. Detailed Financial Data **Profitability Trends:** | Metric | This Year | Last Year | Year Before | 3-Year Trend | |--------|-----------|-----------|-------------|--------------| | Gross Margin | [Data unavailable] | [Data unavailable] | [Data unavailable] | [Data unavailable] | | Net Margin | [Data unavailable] | [Data unavailable] | [Data unavailable] | [Data unavailable] | | ROE | 2.85% | [Data unavailable] | [Data unavailable] | [Data unavailable] | **Growth Trends:** | Metric | This Year | Last Year | Year Before | 3-Year Trend | |--------|-----------|-----------|-------------|--------------| | Revenue Growth | [Data unavailable] | [Data unavailable] | [Data unavailable] | [Data unavailable] | | Profit Growth | [Data unavailable] | [Data unavailable] | [Data unavailable] | [Data unavailable] | | EPS Growth | [Data unavailable] | [Data unavailable] | [Data unavailable] | [Data unavailable] | --- #### II. Earnings Track Record **Last 4 Quarters vs Expectations:** | Quarter | EPS Expected | EPS Actual | Surprise | |---------|--------------|------------|----------| | [Data unavailable] | [Data unavailable] | [Data unavailable] | [Data unavailable] | | [Data unavailable] | [Data unavailable] | [Data unavailable] | [Data unavailable] | | [Data unavailable] | [Data unavailable] | [Data unavailable] | [Data unavailable] | | [Data unavailable] | [Data unavailable] | [Data unavailable] | [Data unavailable] | **Earnings Trend Interpretation:** [Data unavailable] — no earnings history was provided, so there is no clean way to judge whether the company is consistently beating expectations or still struggling to establish credibility. --- #### III. What the Market Thinks **Analyst Ratings:** | Rating | Count | Percentage | |--------|-------|------------| | Strong Buy/Buy | 0 firms | 0% | | Hold | 0 firms | 0% | | Sell | 0 firms | 0% | **Target Price:** [Data unavailable] ~ [Data unavailable] (Median [Data unavailable]) **vs Current Price:** [Data unavailable] **Insider Activity:** [Data unavailable] in past 3 months > No insider transaction data was provided. For a small and newly listed stock, that missing transparency matters more than usual. --- #### IV. Key Risk Alerts **3 Risks to Watch:** 1. **Liquidity Risk:** Extremely low current and quick ratios suggest weak short-term funding flexibility → If this is not improved, it could lead to operational strain or a need for external financing. 2. **Valuation Risk:** A trailing PE above 120x despite weak return metrics leaves little margin for execution mistakes → If growth disappoints, the stock could rerate sharply lower. 3. **Information Risk:** There is very limited business, earnings, analyst, and news data in this dataset → If investors are buying without clear fundamental visibility, price swings can become detached from reality. --- ### 🎬 Summary & Next Steps > **📝 Three-Sentence Summary** > > **What it is:** AFJK is a tiny, newly public NASDAQ-listed company that currently looks more like a speculative trading vehicle than a fully transparent fundamental story. > > **Key strength:** The balance sheet appears to carry very little debt, and the stock clearly has the ability to attract aggressive market attention. > > **Key risk:** The combination of extreme liquidity weakness, thin disclosed operating detail, and a very high PE makes this one hard to underwrite on fundamentals alone. --- > **🔍 Want to Learn More?** > > • Want to know if this company has a strong moat? → Try【Buffett Mode】for deeper analysis > > • Want to check for hidden landmines? → Try【Muddy Mode】for risk screening > > • Is this a growth stock? Want to calculate if it's worth the bet? → Try【Musk Mode】for analysis